SIMILAR PATTERNS OF AMINO ACIDS FOR 3WEM_A_ACRA1001
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gny | XYLANASE 10C (Cellvibriojaponicus) |
PF03426(CBM_15) | 5 | ALA A 240ASN A 92ASP A 205ASP A 207ASP A 146 | None | 1.23A | 3wemA-1gnyA:undetectable | 3wemA-1gnyA:9.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1t0a | 2C-METHYL-D-ERYTHRITOL2,4-CYCLODIPHOSPHATESYNTHASE (Shewanellaoneidensis) |
PF02542(YgbB) | 5 | ALA A 120ASP A 40ILE A 21ASP A 74ASP A 121 | None | 1.41A | 3wemA-1t0aA:undetectable | 3wemA-1t0aA:9.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1t3q | QUINOLINE2-OXIDOREDUCTASELARGE SUBUNIT (Pseudomonasputida) |
PF01315(Ald_Xan_dh_C)PF02738(Ald_Xan_dh_C2) | 5 | ASP B 159ALA B 157ASN B 164ILE B 57ARG B 110 | SO4 B3105 ( 4.8A)NoneNoneNoneSO4 B3105 (-2.9A) | 1.43A | 3wemA-1t3qB:undetectable | 3wemA-1t3qB:22.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1to5 | SUPEROXIDE DISMUTASE (Schistosomamansoni) |
PF00080(Sod_Cu) | 5 | ASP A 100PHE A 63ASP A 123ARG A 78HIS A 70 | NoneNoneNoneNone ZN A 711 (-3.1A) | 1.48A | 3wemA-1to5A:undetectable | 3wemA-1to5A:10.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vkz | PHOSPHORIBOSYLAMINE--GLYCINE LIGASE (Thermotogamaritima) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ASP A 280ALA A 347ASN A 35ILE A 398ARG A 362 | None | 1.21A | 3wemA-1vkzA:undetectable | 3wemA-1vkzA:17.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xc6 | BETA-GALACTOSIDASE (Penicillium sp.) |
PF01301(Glyco_hydro_35)PF10435(BetaGal_dom2)PF13363(BetaGal_dom3)PF13364(BetaGal_dom4_5) | 5 | ALA A 622PHE A 624ILE A 369ASP A 80ASP A 623 | None | 1.37A | 3wemA-1xc6A:7.6 | 3wemA-1xc6A:22.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2anp | LEUCYLAMINOPEPTIDASE (Vibrioproteolyticus) |
PF04389(Peptidase_M28) | 5 | ALA A 231ASN A 235ASP A 117ILE A 255HIS A 97 | NoneNone ZN A 501 ( 2.4A)None ZN A 502 (-3.3A) | 1.49A | 3wemA-2anpA:undetectable | 3wemA-2anpA:14.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cun | PHOSPHOGLYCERATEKINASE (Pyrococcushorikoshii) |
PF00162(PGK) | 5 | ALA A 148ASN A 146ASP A 65ASP A 19HIS A 360 | NoneNoneNoneGOL A 501 (-2.6A)3PG A 503 (-4.0A) | 1.39A | 3wemA-2cunA:undetectable | 3wemA-2cunA:17.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cun | PHOSPHOGLYCERATEKINASE (Pyrococcushorikoshii) |
PF00162(PGK) | 5 | ALA A 148ASN A 146ILE A 29ASP A 19HIS A 360 | NoneNoneNoneGOL A 501 (-2.6A)3PG A 503 (-4.0A) | 1.11A | 3wemA-2cunA:undetectable | 3wemA-2cunA:17.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2d4y | FLAGELLARHOOK-ASSOCIATEDPROTEIN 1 (Salmonellaenterica) |
no annotation | 5 | ALA A 250ASN A 337ASP A 154ASP A 291ASP A 251 | None | 1.21A | 3wemA-2d4yA:undetectable | 3wemA-2d4yA:18.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 6 | ALA A 88ASP A 212ILE A 213ASP A 320MET A 321ARG A 400 | NoneNoneNoneNoneBOG A2000 ( 4.0A)BOG A2000 (-3.1A) | 1.18A | 3wemA-2g3nA:40.8 | 3wemA-2g3nA:26.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 6 | ASP A 87ALA A 90ASP A 212ILE A 213PHE A 449HIS A 480 | BOG A2000 (-2.7A)NoneNoneNoneNoneNone | 0.96A | 3wemA-2g3nA:40.8 | 3wemA-2g3nA:26.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 9 | ASP A 87ASP A 212ILE A 213ASP A 320MET A 321ARG A 400ASP A 416PHE A 449HIS A 480 | BOG A2000 (-2.7A)NoneNoneNoneBOG A2000 ( 4.0A)BOG A2000 (-3.1A)BOG A2000 (-3.0A)NoneNone | 0.30A | 3wemA-2g3nA:40.8 | 3wemA-2g3nA:26.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 7 | ASP A 87ASP A 212ILE A 249MET A 321ASP A 416PHE A 449HIS A 480 | BOG A2000 (-2.7A)NoneNoneBOG A2000 ( 4.0A)BOG A2000 (-3.0A)NoneNone | 1.44A | 3wemA-2g3nA:40.8 | 3wemA-2g3nA:26.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ASP A 416ALA A 88ASP A 251ILE A 249ASP A 87 | BOG A2000 (-3.0A)NoneNoneNoneBOG A2000 (-2.7A) | 1.26A | 3wemA-2g3nA:40.8 | 3wemA-2g3nA:26.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pbp | ENOYL-COA HYDRATASESUBUNIT I (Geobacilluskaustophilus) |
PF00378(ECH_1) | 5 | ALA A 126PHE A 128ILE A 17MET A 187PHE A 62 | None | 1.47A | 3wemA-2pbpA:undetectable | 3wemA-2pbpA:15.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qk4 | TRIFUNCTIONAL PURINEBIOSYNTHETIC PROTEINADENOSINE-3 (Homo sapiens) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ASP A 295ALA A 370ASN A 36ILE A 421ARG A 385 | NoneNoneNoneNoneGOL A 804 (-4.2A) | 1.23A | 3wemA-2qk4A:undetectable | 3wemA-2qk4A:18.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w20 | SIALIDASE A (Streptococcuspneumoniae) |
PF13088(BNR_2) | 5 | ASN A 599ASP A 417ILE A 348ASP A 372PHE A 565 | None | 1.48A | 3wemA-2w20A:2.5 | 3wemA-2w20A:20.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x2i | ALPHA-1,4-GLUCANLYASE ISOZYME 1 (Gracilariopsislemaneiformis) |
PF01055(Glyco_hydro_31) | 5 | ASP A 239ASN A 242ASP A 553MET A 554ARG A 649 | QPS A1050 (-2.5A)NoneQPS A1050 (-3.1A)QPS A1050 (-3.1A)QPS A1050 (-3.2A) | 1.12A | 3wemA-2x2iA:32.5 | 3wemA-2x2iA:24.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x2i | ALPHA-1,4-GLUCANLYASE ISOZYME 1 (Gracilariopsislemaneiformis) |
PF01055(Glyco_hydro_31) | 9 | ASP A 239ASN A 244ASP A 412ASP A 553MET A 554ARG A 649ASP A 665PHE A 698HIS A 731 | QPS A1050 (-2.5A)NoneQPS A1050 (-3.2A)QPS A1050 (-3.1A)QPS A1050 (-3.1A)QPS A1050 (-3.2A)QPS A1050 (-2.7A)QPS A1050 (-4.3A)QPS A1050 (-4.3A) | 0.65A | 3wemA-2x2iA:32.5 | 3wemA-2x2iA:24.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xr1 | CLEAVAGE ANDPOLYADENYLATIONSPECIFICITY FACTOR100 KD SUBUNIT (Methanosarcinamazei) |
PF07521(RMMBL)PF07650(KH_2)PF10996(Beta-Casp)PF16661(Lactamase_B_6)PF17214(KH_7) | 5 | ALA A 327ASN A 326ASP A 246ASP A 209HIS A 604 | NoneNone ZN A1639 (-2.7A)None ZN A1639 (-3.3A) | 1.33A | 3wemA-2xr1A:undetectable | 3wemA-2xr1A:22.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 6 | ASP A 470ASP A 582ARG A 642ASP A 659PHE A 692HIS A 740 | None | 0.52A | 3wemA-2xvgA:34.5 | 3wemA-2xvgA:25.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yw2 | PHOSPHORIBOSYLAMINE--GLYCINE LIGASE (Aquifexaeolicus) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ASP A 290ALA A 363ASN A 34ILE A 414ARG A 378 | NoneNoneNoneNonePO4 A 645 (-3.6A) | 1.28A | 3wemA-2yw2A:undetectable | 3wemA-2yw2A:18.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3af5 | PUTATIVEUNCHARACTERIZEDPROTEIN PH1404 (Pyrococcushorikoshii) |
PF07521(RMMBL)PF10996(Beta-Casp)PF16661(Lactamase_B_6)PF17214(KH_7) | 5 | ALA A 342ASN A 341ASP A 260ASP A 217HIS A 618 | NoneACY A 658 (-3.4A) ZN A 665 ( 2.9A)None ZN A 665 ( 3.3A) | 1.30A | 3wemA-3af5A:2.1 | 3wemA-3af5A:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ce1 | SUPEROXIDE DISMUTASE[CU-ZN] (Naganishialiquefaciens) |
PF00080(Sod_Cu) | 5 | ASP A 105PHE A 68ASP A 128ARG A 83HIS A 75 | NoneNoneNoneNone ZN A 202 (-3.1A) | 1.47A | 3wemA-3ce1A:2.0 | 3wemA-3ce1A:10.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 10 | ASP A 203ASN A 207ASP A 327ILE A 328ASP A 443MET A 444ARG A 526ASP A 542PHE A 575HIS A 600 | GOL A3001 (-2.6A)None3CU A1001 (-2.7A)3CU A1001 ( 3.9A)3CU A1001 (-2.7A)3CU A1001 ( 3.9A)3CU A1001 ( 3.5A)3CU A1001 ( 2.5A)3CU A1001 (-4.5A)3CU A1001 (-3.9A) | 0.71A | 3wemA-3cttA:47.4 | 3wemA-3cttA:36.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fnb | ACYLAMINOACYLPEPTIDASE SMU_737 (Streptococcusmutans) |
PF12146(Hydrolase_4) | 5 | ASN A 63ASP A 191ASP A 171ARG A 97PHE A 114 | None | 1.18A | 3wemA-3fnbA:undetectable | 3wemA-3fnbA:17.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i4g | SUSD-LIKECARBOHYDRATE BINDINGPROTEIN BF1063 (Bacteroidesfragilis) |
PF07980(SusD_RagB)PF14322(SusD-like_3) | 5 | ALA A 467ASN A 80ILE A 250ARG A 336PHE A 258 | None | 1.41A | 3wemA-3i4gA:undetectable | 3wemA-3i4gA:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ikf | 2-C-METHYL-D-ERYTHRITOL2,4-CYCLODIPHOSPHATESYNTHASE (Burkholderiapseudomallei) |
PF02542(YgbB) | 5 | ALA A 120ASP A 40ILE A 21ASP A 74ASP A 121 | None | 1.41A | 3wemA-3ikfA:undetectable | 3wemA-3ikfA:11.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3km2 | SUPEROXIDE DISMUTASE[CU-ZN],CHLOROPLASTIC (Solanumlycopersicum) |
PF00080(Sod_Cu) | 5 | ASP A 101ASN A 110ASP A 124ARG A 79HIS A 71 | NoneNoneNoneNone ZN A 155 (-3.2A) | 1.46A | 3wemA-3km2A:undetectable | 3wemA-3km2A:10.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 9 | ASP A 231ASP A 355ILE A 356ASP A 472MET A 473ARG A 555ASP A 571PHE A 604HIS A 629 | NoneTRS A6001 (-2.9A)TRS A6001 ( 4.0A)TRS A6001 (-3.2A)TRS A6001 ( 3.7A)TRS A6001 ( 4.6A)TRS A6001 ( 3.7A)TRS A6001 (-4.4A)TRS A6001 (-4.2A) | 0.32A | 3wemA-3lppA:51.5 | 3wemA-3lppA:35.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 7 | ASP A 231ASP A 355ILE A 392MET A 473ASP A 571PHE A 604HIS A 629 | NoneTRS A6001 (-2.9A)NoneTRS A6001 ( 3.7A)TRS A6001 ( 3.7A)TRS A6001 (-4.4A)TRS A6001 (-4.2A) | 1.47A | 3wemA-3lppA:51.5 | 3wemA-3lppA:35.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ogr | BETA-GALACTOSIDASE (Trichodermareesei) |
PF01301(Glyco_hydro_35)PF10435(BetaGal_dom2)PF13363(BetaGal_dom3)PF13364(BetaGal_dom4_5) | 5 | ALA A 624PHE A 626ILE A 368ASP A 80ASP A 625 | None | 1.31A | 3wemA-3ogrA:7.7 | 3wemA-3ogrA:23.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3om5 | LEVANSUCRASE (Bacillusmegaterium) |
PF02435(Glyco_hydro_68) | 5 | ASP A 90ALA A 79PHE A 133ASN A 147ASP A 448 | None | 1.44A | 3wemA-3om5A:undetectable | 3wemA-3om5A:18.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ALA A 448ASN A 431ASP A 197ILE A 234ASP A 449 | NoneNoneACR A 664 (-2.9A)NoneNone | 1.32A | 3wemA-3pocA:35.2 | 3wemA-3pocA:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 8 | ASP A 73ASP A 197ILE A 198MET A 308ARG A 404ASP A 420PHE A 453HIS A 478 | NoneACR A 664 (-2.9A)ACR A 664 (-3.5A)ACR A 664 ( 3.8A)ACR A 664 (-4.0A)ACR A 664 (-2.8A)ACR A 664 (-4.4A)ACR A 664 (-4.2A) | 0.34A | 3wemA-3pocA:35.2 | 3wemA-3pocA:26.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 9 | ASP A1157ASP A1279ILE A1280ASP A1420MET A1421ARG A1510ASP A1526PHE A1559HIS A1584 | ACR A 1 (-2.6A)ACR A 1 (-3.2A)ACR A 1 (-4.1A)ACR A 1 (-3.6A)ACR A 1 (-3.5A)ACR A 1 (-2.9A)ACR A 1 (-2.8A)ACR A 1 (-4.3A)ACR A 1 (-3.9A) | 0.41A | 3wemA-3topA:44.5 | 3wemA-3topA:34.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ugk | SACCHAROPINEDEHYDROGENASE [NAD+,L-LYSINE-FORMING] (Saccharomycescerevisiae) |
PF05222(AlaDh_PNT_N) | 5 | ALA A 165ASN A 299ASP A 182ARG A 149HIS A 157 | None | 1.13A | 3wemA-3ugkA:undetectable | 3wemA-3ugkA:18.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w9u | PUTATIVE LIPASE (Proteusmirabilis) |
PF00561(Abhydrolase_1) | 5 | ASP A 213ALA A 262PHE A 22ASP A 253HIS A 78 | None | 1.16A | 3wemA-3w9uA:undetectable | 3wemA-3w9uA:16.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wc3 | ENDO-1,4-BETA-GLUCANASE (Eisenia fetida) |
PF00759(Glyco_hydro_9) | 5 | ASP A 60ALA A 159ASN A 63ASP A 77ARG A 157 | None | 1.50A | 3wemA-3wc3A:undetectable | 3wemA-3wc3A:19.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 12 | ASP A 232ALA A 234PHE A 236ASN A 237ASP A 357ILE A 358ASP A 469MET A 470ARG A 552ASP A 568PHE A 601HIS A 626 | ACR A1001 (-2.7A)ACR A1001 (-3.7A)ACR A1001 (-4.9A)ACR A1001 (-3.0A)ACR A1001 (-3.0A)ACR A1001 (-3.6A)ACR A1001 (-3.2A)ACR A1001 (-3.3A)ACR A1001 (-3.0A)ACR A1001 (-2.7A)ACR A1001 (-4.3A)ACR A1001 (-4.1A) | 0.16A | 3wemA-3welA:62.2 | 3wemA-3welA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 9 | ASP A 232ALA A 234PHE A 236ASN A 237ASP A 357ILE A 396MET A 470ASP A 568PHE A 601 | ACR A1001 (-2.7A)ACR A1001 (-3.7A)ACR A1001 (-4.9A)ACR A1001 (-3.0A)ACR A1001 (-3.0A)ACR A1001 (-4.9A)ACR A1001 (-3.3A)ACR A1001 (-2.7A)ACR A1001 (-4.3A) | 1.41A | 3wemA-3welA:62.2 | 3wemA-3welA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wjs | NADH OXIDASE (Gluconobacteroxydans) |
PF00724(Oxidored_FMN) | 5 | ASP A 294ALA A 313ASP A 230ARG A 261HIS A 172 | NoneNone HG A 403 ( 4.8A)NoneNone | 1.22A | 3wemA-3wjsA:8.9 | 3wemA-3wjsA:16.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ayg | GLUCANSUCRASE (Lactobacillusreuteri) |
PF01473(CW_binding_1)PF02324(Glyco_hydro_70) | 5 | ASP A 934ALA A1737PHE A1753ASP A1767ASP A1754 | None | 1.03A | 3wemA-4aygA:2.6 | 3wemA-4aygA:22.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 6 | ASP A 299ASP A 412ARG A 463ASP A 480PHE A 513HIS A 540 | None | 0.44A | 3wemA-4b9yA:42.3 | 3wemA-4b9yA:25.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASP A 299ILE A 341ASP A 480PHE A 513HIS A 540 | None | 1.36A | 3wemA-4b9yA:42.3 | 3wemA-4b9yA:25.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c8g | 2-C-METHYL-D-ERYTHRITOL2,4-CYCLODIPHOSPHATESYNTHASE (Burkholderiacenocepacia) |
PF02542(YgbB) | 5 | ALA A 120ASP A 40ILE A 21ASP A 74ASP A 121 | None | 1.46A | 3wemA-4c8gA:undetectable | 3wemA-4c8gA:11.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4di5 | 5-EPI-ARISTOLOCHENESYNTHASE (Nicotianatabacum) |
PF01397(Terpene_synth)PF03936(Terpene_synth_C) | 5 | ASP A 444ALA A 447ASN A 523ASP A 302ASP A 525 | DPO A 605 (-2.6A)NoneNoneNoneDPO A 605 ( 4.6A) | 1.40A | 3wemA-4di5A:undetectable | 3wemA-4di5A:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) |
PF01301(Glyco_hydro_35)PF10435(BetaGal_dom2)PF13363(BetaGal_dom3)PF13364(BetaGal_dom4_5) | 5 | ALA A 619PHE A 621ILE A 368ASP A 80ASP A 620 | None | 1.36A | 3wemA-4iugA:5.7 | 3wemA-4iugA:22.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nen | INTEGRIN ALPHA-XINTEGRIN BETA-2 (Homo sapiens) |
PF00092(VWA)PF00362(Integrin_beta)PF01839(FG-GAP)PF07965(Integrin_B_tail)PF08441(Integrin_alpha2)PF17205(PSI_integrin) | 5 | ASP A 663PHE A 608ILE B 482ASP A 706ARG A 670 | None | 1.24A | 3wemA-4nenA:3.0 | 3wemA-4nenA:23.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o7p | MALTOKINASE (Mycobacteriumtuberculosis) |
no annotation | 5 | ASP A 402PHE A 368ASN A 396ASP A 411ARG A 413 | None | 1.45A | 3wemA-4o7pA:undetectable | 3wemA-4o7pA:20.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4p22 | UBIQUITIN-LIKEMODIFIER-ACTIVATINGENZYME 1 (Homo sapiens) |
PF00899(ThiF)PF16190(E1_FCCH)PF16191(E1_4HB) | 5 | ALA A 428PHE A 426ASP A 379ASP A 427PHE A 323 | None | 1.43A | 3wemA-4p22A:undetectable | 3wemA-4p22A:19.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qpm | MITOTIC CHECKPOINTSERINE/THREONINE-PROTEIN KINASE BUB1 (Homo sapiens) |
PF00069(Pkinase) | 5 | ALA A 993PHE A 989ASP A 946ASP A 921HIS A 915 | NoneNone MG A1503 (-1.7A)NoneNone | 1.47A | 3wemA-4qpmA:undetectable | 3wemA-4qpmA:17.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rvp | SUPEROXIDE DISMUTASE (Sedum alfredii) |
PF00080(Sod_Cu) | 5 | ASP A 113ASN A 122ASP A 136ARG A 91HIS A 83 | NoneNoneNoneNone ZN A 201 (-3.1A) | 1.46A | 3wemA-4rvpA:undetectable | 3wemA-4rvpA:10.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rxu | PERIPLASMICSUGAR-BINDINGPROTEIN (Chloroflexusaurantiacus) |
PF13407(Peripla_BP_4) | 5 | ASP A 138PHE A 72ASP A 298ARG A 64ASP A 68 | BGC A 402 (-3.0A)NoneBGC A 402 (-2.7A)BGC A 402 (-3.9A)None | 1.45A | 3wemA-4rxuA:undetectable | 3wemA-4rxuA:17.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wqe | THIOSULFATEDEHYDROGENASE (Allochromatiumvinosum) |
PF13442(Cytochrome_CBB3) | 5 | ALA A 174ASP A 34ARG A 177ASP A 173HIS A 51 | NoneNoneNoneNoneHEC A1002 (-4.9A) | 1.45A | 3wemA-4wqeA:undetectable | 3wemA-4wqeA:15.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4x81 | MYCINAMICIN III3''-O-METHYLTRANSFERASE (Micromonosporagriseorubida) |
PF05711(TylF) | 5 | ASP A 244ASP A 191ILE A 220ASP A 216ARG A 61 | NoneMVI A 305 ( 2.7A)MVI A 305 ( 4.3A) MG A 304 ( 2.9A)MVI A 305 ( 4.3A) | 1.47A | 3wemA-4x81A:undetectable | 3wemA-4x81A:15.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xeq | TRAP DICARBOXYLATETRANSPORTER, DCTPSUBUNIT (Desulfovibriovulgaris) |
PF03480(DctP) | 5 | ASP A 133ALA A 128PHE A 122ARG A 279HIS A 247 | NoneNoneNoneNonePAF A 401 (-4.1A) | 1.41A | 3wemA-4xeqA:undetectable | 3wemA-4xeqA:16.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xeq | TRAP DICARBOXYLATETRANSPORTER, DCTPSUBUNIT (Desulfovibriovulgaris) |
PF03480(DctP) | 5 | ASP A 133ALA A 128PHE A 122ILE A 100ARG A 279 | None | 1.19A | 3wemA-4xeqA:undetectable | 3wemA-4xeqA:16.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ypv | EST8 (Parvibaculum) |
PF07859(Abhydrolase_3) | 5 | ALA A 290ASP A 158ILE A 186ASP A 42HIS A 97 | None | 1.43A | 3wemA-4ypvA:undetectable | 3wemA-4ypvA:14.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z11 | AURONE SYNTHASE (Coreopsisgrandiflora) |
PF00264(Tyrosinase)PF12142(PPO1_DWL)PF12143(PPO1_KFDV) | 5 | ASP A 429PHE A 425ILE A 198ARG A 496ASP A 192 | None | 1.23A | 3wemA-4z11A:undetectable | 3wemA-4z11A:20.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cdc | VP1, STRUCTURALPOLYPROTEIN (Israeli acuteparalysis virus) |
PF08762(CRPV_capsid) | 5 | ASP A 76ALA A 183ILE A 156ASP A 71PHE A 188 | None | 1.43A | 3wemA-5cdcA:undetectable | 3wemA-5cdcA:13.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5djw | ALPHA-GLUCOSIDASE II (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 5 | ALA A 90ASP A 211ILE A 212ASP A 321ARG A 385 | None | 1.08A | 3wemA-5djwA:36.2 | 3wemA-5djwA:28.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5djw | ALPHA-GLUCOSIDASE II (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 5 | ASP A 211ASP A 321ARG A 385ASP A 401PHE A 434 | None | 1.46A | 3wemA-5djwA:36.2 | 3wemA-5djwA:28.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 9 | ASP A 303ASP A 443ILE A 444ASP A 556MET A 557ARG A 617ASP A 633PHE A 666HIS A 691 | NoneTRS A1001 (-2.9A)TRS A1001 ( 4.1A)TRS A1001 (-3.2A)TRS A1001 (-3.5A)TRS A1001 (-4.0A)TRS A1001 (-2.8A)TRS A1001 (-4.5A)TRS A1001 (-4.0A) | 0.33A | 3wemA-5dkxA:42.7 | 3wemA-5dkxA:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 8 | ASP A 303ASP A 443ILE A 480MET A 557ARG A 617ASP A 633PHE A 666HIS A 691 | NoneTRS A1001 (-2.9A)NoneTRS A1001 (-3.5A)TRS A1001 (-4.0A)TRS A1001 (-2.8A)TRS A1001 (-4.5A)TRS A1001 (-4.0A) | 1.33A | 3wemA-5dkxA:42.7 | 3wemA-5dkxA:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5e3e | CDII IMMUNITYPROTEIN (Yersiniakristensenii) |
no annotation | 5 | ALA A 35PHE A 26ILE A 52MET A 97PHE A 18 | None | 1.30A | 3wemA-5e3eA:undetectable | 3wemA-5e3eA:8.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7c | ALPHA-GLUCOSIDASE (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 6 | ASP A 228ASN A 234ASP A 348ASP A 460ARG A 507PHE A 556 | None | 1.02A | 3wemA-5f7cA:33.7 | 3wemA-5f7cA:24.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7c | ALPHA-GLUCOSIDASE (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 7 | ASP A 228ASP A 348ASP A 460ARG A 507ASP A 523PHE A 556HIS A 588 | None | 0.49A | 3wemA-5f7cA:33.7 | 3wemA-5f7cA:24.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7s | GLYCOSIDE HYDROLASEFAMILY 31 (Trueperellapyogenes) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ASP A 467ARG A 516ASP A 532PHE A 565HIS A 591 | CA A 805 (-2.9A) CA A 805 ( 4.6A) CA A 805 ( 4.6A)NoneNone | 0.56A | 3wemA-5f7sA:35.3 | 3wemA-5f7sA:21.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 9 | ASP A 305ASP A 451ILE A 452ASP A 564MET A 565ARG A 624ASP A 640PHE A 673HIS A 698 | None5GF A1021 (-2.0A)5GF A1021 (-3.6A)5GF A1021 (-2.1A)5GF A1021 (-2.6A)5GF A1021 (-3.4A)5GF A1021 (-2.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 0.31A | 3wemA-5hjrA:40.9 | 3wemA-5hjrA:29.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 8 | ASP A 305ASP A 451ILE A 488MET A 565ARG A 624ASP A 640PHE A 673HIS A 698 | None5GF A1021 (-2.0A)None5GF A1021 (-2.6A)5GF A1021 (-3.4A)5GF A1021 (-2.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 1.28A | 3wemA-5hjrA:40.9 | 3wemA-5hjrA:29.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ip9 | DNA-DIRECTED RNAPOLYMERASE IISUBUNIT RPB2 (Saccharomycescerevisiae) |
PF00562(RNA_pol_Rpb2_6)PF04560(RNA_pol_Rpb2_7)PF04561(RNA_pol_Rpb2_2)PF04563(RNA_pol_Rpb2_1)PF04565(RNA_pol_Rpb2_3)PF04566(RNA_pol_Rpb2_4)PF04567(RNA_pol_Rpb2_5) | 5 | ALA B 793ASN B 794ILE B 204ARG B 788ASP B 790 | None | 1.46A | 3wemA-5ip9B:undetectable | 3wemA-5ip9B:21.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jd3 | LAE5 (unculturedbacterium) |
PF13472(Lipase_GDSL_2) | 5 | ALA A 150ASP A 172ASP A 178ARG A 144ASP A 153 | SO4 A 303 (-3.2A)NoneNoneNoneNone | 1.44A | 3wemA-5jd3A:undetectable | 3wemA-5jd3A:13.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASN A 319ASP A 441ASP A 553ARG A 613HIS A 709 | NoneEDO A1008 (-2.8A)EDO A1008 (-2.7A)EDO A1008 (-4.6A)EDO A1008 (-4.0A) | 1.13A | 3wemA-5jouA:34.4 | 3wemA-5jouA:25.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 6 | ASP A 441ASP A 553ARG A 613ASP A 630PHE A 663HIS A 709 | EDO A1008 (-2.8A)EDO A1008 (-2.7A)EDO A1008 (-4.6A)EDO A1008 (-3.0A)EDO A1008 (-4.3A)EDO A1008 (-4.0A) | 0.46A | 3wemA-5jouA:34.4 | 3wemA-5jouA:25.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lhk | LEUCINEAMINOPEPTIDASE 2,CHLOROPLASTIC (Streptomycessp. BC16019) |
PF00883(Peptidase_M17)PF02789(Peptidase_M17_N) | 5 | ASP A 440ALA A 445PHE A 390ASP A 284ARG A 347 | NoneNoneNone MN A 601 (-2.2A)BCT A 603 (-3.8A) | 1.31A | 3wemA-5lhkA:undetectable | 3wemA-5lhkA:20.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 9 | ASP A 282ALA A 284ASP A 404ASP A 518MET A 519ARG A 600ASP A 616PHE A 649HIS A 674 | ACR A1015 (-2.6A)ACR A1015 ( 4.6A)ACR A1015 (-3.0A)ACR A1015 (-3.1A)ACR A1015 (-3.3A)ACR A1015 (-3.1A)ACR A1015 (-2.7A)ACR A1015 (-4.3A)ACR A1015 (-4.0A) | 0.30A | 3wemA-5nn8A:47.3 | 3wemA-5nn8A:37.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 7 | ASP A 282ALA A 284ASP A 404ILE A 441MET A 519ASP A 616PHE A 649 | ACR A1015 (-2.6A)ACR A1015 ( 4.6A)ACR A1015 (-3.0A)ACR A1015 (-4.3A)ACR A1015 (-3.3A)ACR A1015 (-2.7A)ACR A1015 (-4.3A) | 1.45A | 3wemA-5nn8A:47.3 | 3wemA-5nn8A:37.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vev | PHOSPHORIBOSYLAMINE--GLYCINE LIGASE (Neisseriagonorrhoeae) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ASP A 291ALA A 364ASN A 34ILE A 416ARG A 380 | NoneNoneNoneNoneSO4 A 511 (-3.8A) | 1.29A | 3wemA-5vevA:undetectable | 3wemA-5vevA:20.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x7s | GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE (Paenibacillussp. 598K) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF16990(CBM_35)PF17137(DUF5110) | 5 | ASP A 429ARG A 474ASP A 491PHE A 533HIS A 565 | None | 0.40A | 3wemA-5x7sA:18.2 | 3wemA-5x7sA:21.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 4 | TRP A 327TRP A 435TRP A 470TRP A 568 | TRS A6001 ( 3.8A)TRS A6001 ( 4.6A)NoneNone | 0.38A | 3wemA-3lppA:51.5 | 3wemA-3lppA:35.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 4 | TRP A 169TRP A 271TRP A 305TRP A 417 | ACR A 664 (-3.7A)ACR A 664 (-4.6A)NoneACR A 664 (-4.6A) | 1.06A | 3wemA-3pocA:35.4 | 3wemA-3pocA:26.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 5 | ILE A 233TRP A 329TRP A 432TRP A 467TRP A 565 | GLC A1002 (-3.9A)ACR A1001 (-4.1A)ACR A1001 ( 4.6A)NoneACR A1001 (-4.8A) | 0.29A | 3wemA-3welA:62.2 | 3wemA-3welA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zm8 | GH26ENDO-BETA-1,4-MANNANASE (Podosporaanserina) |
PF02156(Glyco_hydro_26)PF16990(CBM_35) | 4 | ILE A 273TRP A 295TRP A 308TRP A 307 | None | 1.48A | 3wemA-3zm8A:0.4 | 3wemA-3zm8A:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 4 | TRP A 415TRP A 517TRP A 554TRP A 630 | NoneTRS A1001 ( 4.9A)TRS A1001 (-4.9A)None | 0.51A | 3wemA-5dkxA:42.7 | 3wemA-5dkxA:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 4 | TRP A 423TRP A 525TRP A 562TRP A 637 | 5GF A1021 (-3.1A)5GF A1021 (-3.7A)5GF A1021 (-4.6A)5GF A1021 ( 4.6A) | 0.54A | 3wemA-5hjrA:40.9 | 3wemA-5hjrA:29.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jp9 | CMP5-HYDROXYMETHYLASE (Streptomycesrimofaciens) |
PF00303(Thymidylat_synt) | 4 | ILE A 205TRP A 285TRP A 251TRP A 119 | None | 1.40A | 3wemA-5jp9A:0.0 | 3wemA-5jp9A:15.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jwy | PHOSPHATIDYLGLYCEROPHOSPHATASE B (Escherichiacoli) |
PF01569(PAP2) | 4 | ILE A 116TRP A 29TRP A 151TRP A 208 | None | 1.34A | 3wemA-5jwyA:0.3 | 3wemA-5jwyA:15.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 4 | TRP A 376TRP A 481TRP A 516TRP A 613 | ACR A1015 ( 4.6A)ACR A1015 ( 4.6A)NoneACR A1015 (-4.8A) | 0.86A | 3wemA-5nn8A:47.3 | 3wemA-5nn8A:37.15 |